Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
33,289,095
-
Number of holders
-
47
-
Total 13F shares, excl. options
-
3,292,636
-
Shares change
-
+490,520
-
Total reported value, excl. options
-
$44,309,081
-
Value change
-
+$5,759,072
-
Number of buys
-
26
-
Number of sells
-
-14
-
Price
-
$13.46
Significant Holders of XBiotech Inc. - Common Shares, no par value (XBIT) as of Q3 2016
54 filings reported holding XBIT - XBiotech Inc. - Common Shares, no par value as of Q3 2016.
XBiotech Inc. - Common Shares, no par value (XBIT) has 47 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3,292,636 shares
of 33,289,095 outstanding shares and own 9.89% of the company stock.
Largest 10 shareholders include BlackRock Fund Advisors (915,494 shares), VANGUARD GROUP INC (687,883 shares), STATE STREET CORP (267,546 shares), BlackRock Institutional Trust Company, N.A. (215,217 shares), NORTHERN TRUST CORP (212,185 shares), GEODE CAPITAL MANAGEMENT, LLC (143,040 shares), CADIAN CAPITAL MANAGEMENT, LP (139,829 shares), Bank of New York Mellon Corp (67,807 shares), BlackRock Investment Management, LLC (66,957 shares), and SCHWAB CHARLES INVESTMENT MANAGEMENT INC (57,053 shares).
This table shows the top 47 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.